Drug Shortage Report for HEMABATE

Last updated on 2022-11-24 History
Report ID 175483
Drug Identification Number 02230417
Brand name HEMABATE
Common or Proper name HEMABATE
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) CARBOPROST
Strength(s) 250MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10 x 1mL amp
ATC code G02AD
ATC description UTEROTONICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-23
Estimated end date 2022-12-12
Actual end date
Shortage status Actual shortage
Updated date 2022-11-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-11-23 English Compare
v2 2022-11-23 French Compare
v3 2022-11-24 English Compare

Showing 1 to 3 of 3